Evidence map›Paper›PMID 28764845›Full record

ArticleMetabolism: clinical and experimental2017

Impaired calcium sensing distinguishes primary hyperparathyroidism (PHPT) patients with low bone mineral density.

Thomas J Weber, James Koh, Samantha M Thomas, Joyce A Hogue, Randall P Scheri, Sanziana A Roman, Julie A Sosa

Open access · greenAbstract read
In one paragraph

Article in Metabolism: clinical and experimental, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. The role of miR-139-5p in radioiodine-resistant thyroid cancer.Journal of endocrinological investigation · 2023
    Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Thomas J WeberDept. of Medicine, Duke University Medical Center, Durham, NC, United States. Electronic address: thomas.weber2@dm.duke.edu.
James KohDept. of Surgery, Duke University Medical Center, Durham, NC, United States; Duke Cancer Institute, Duke University Medical Center, United States.
Samantha M ThomasDept. of Biostatistics and Bioinformatics, Duke University, United States; Duke Cancer Institute, Duke University Medical Center, United States.
Joyce A HogueDept. of Surgery, Duke University Medical Center, Durham, NC, United States.
Randall P ScheriDept. of Surgery, Duke University Medical Center, Durham, NC, United States.
Sanziana A RomanDept. of Surgery, Duke University Medical Center, Durham, NC, United States.
Julie A SosaDept. of Medicine, Duke University Medical Center, Durham, NC, United States; Dept. of Surgery, Duke University Medical Center, Durham, NC, United States; Duke Cancer Institute, Duke University Medical Center, United States; Duke Clinical Research Institute, Duke University Medical Center, United States.
Duke Medical Center · USClinical Research Institute · USDuke University · US

Funding

Automated Isolation of Single Cells Using High-Resolution and Subcellular ImagingR44GM119888 · NIGMS · CELL MICROSYSTEMS, INC. · PI GEBHART, STEVEN CHARLES · 2017 to 2018
$1.6M
Single cell analysis of intratumoral heterogeneity in parathyroid neoplasiaR21CA192004 · NCI · DUKE UNIVERSITY · PI KOH, JAMES, SOSA, JULIE ANN · 2015 to 2016
$414k
NCI NIH HHS R21 CA192004NIGMS NIH HHS R44 GM119888
6 · The paper itself

Abstract

contextA subset of PHPT patients exhibit a more severe disease phenotype characterized by bone loss, fractures, recurrent nephrolithiasis, and other dysfunctions, but the underlying reasons for this disparity in clinical presentation remain unknown.

objectiveWe sought to identify new mechanistic indices that could inform more personalized management of PHPT.

designPre-, peri-, and postoperative data and demographic, clinical, and pathological information from patients undergoing parathyroidectomy for PHPT were collected. Univariate and partial Spearman correlation was used to estimate the association of parathyroid tumor calcium sensing capacity with select variables. PATIENTS OR OTHER

participantsAn unselected series of 237 patients aged >18years and undergoing parathyroidectomy for PHPT were enrolled.

main outcome measuresCalcium sensing capacity, expressed as the concentration required for half-maximal biochemical response (EC50), was evaluated in parathyroid tumors from an unselected series of 74 patients and assessed for association with clinical parameters. The hypothesis was that greater disease severity would be associated with attenuated calcium sensitivity and biochemically autonomous parathyroid tumor behavior.

resultsParathyroid tumors segregated into two distinct groups of calcium responsiveness (EC50<3.0 and ≥3.0mM). The low EC50 group (n=27) demonstrated a mean calcium EC50 value of 2.49mM [95% confidence interval (CI): 2.43-2.54mM], consistent with reference normal activity. In contrast, the high EC50 group (n=47) displayed attenuated calcium sensitivity with a mean EC50 value of 3.48mM [95% CI: 3.41-3.55mM]. Retrospective analysis of the clinical registry data suggested that high calcium EC50 patients presented with a more significant preoperative bone mineral density (BMD) deficit with a t-score of -2.7, (95% CI: -3.4 to -1.9) versus 0.9, (95% CI: -2.1 to -0.4) in low EC50 patients (p<0.001). After adjusting for gender, age, BMI, 25 OH vitamin D level and preoperative iPTH, lowest t-score and calcium EC50 were inversely correlated, with a partial Spearman correlation coefficient of -0.35 (p=0.02).

conclusionsImpaired calcium sensing in parathyroid tumors is selectively observed in a subset of patients with more severe bone mineral density deficit. Assessment of parathyroid tumor biochemical behavior may be a useful predictor of disease severity as measured by bone mineral density in patients with PHPT.

Indexed as

Bone DensityAgedCalciumFemaleHumansHyperparathyroidism, PrimaryMaleMiddle AgedParathyroidectomyParathyroid NeoplasmsPerioperative PeriodPhenotypeSeverity of Illness IndexCalciumBone mineral densityCalcium sensingParathyroid tumorsPrimary hyperparathyroidism

Identifiers

PMID28764845
PMCPMC5561769
OpenAlexW2654181259

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.